Live Pfizer updates

Live Pfizer news coverage of developments with the latest updates. Stay on top of latest Pfizer news stories and find out what just happened, what is going on with Pfizer. The latest real-time news updates and headlines on Pfizer
City of Hope to Unveil Cancer Breakthroughs at ASCO
Top Cardiologist Urges Global Heart Health Revamp
Phytomedicine's Dual Role: Long COVID and Heart Health
Lipid Nanoparticle Structure Unveiled for Better Delivery
Breakthrough in Lipid Nanoparticles for Vaccines
CCM Biosciences Unveils AML Drug Data at ASCO 2025
Pfizer Secures Exclusive Licensing Deal With 3SBio
Mucus Plugs Tied to Rapid COPD Lung Decline
Supervising For Success
Business Leaders Appointed to Manage Key Suppliers
Dose Of Hi Pioneers Of UConn Pharmacy
Tailored Biopsies Boost Patient Outcomes
Vaccine Arm Choice Key to Immune Response: Study
Pfizer Combo Boosts Survival in High-Risk Bladder Cancer
Pfizer Unveils 2025 Shareholder Meeting Results
Pfizer Unveils Bold Cancer Care Vision at ASCO 2025
Pfizer Announces Q2 2025 Dividend
Older Adults Thrive on Immunotherapy Despite Age Gaps
Immunotherapy Effective in Seniors Despite Immune Changes
ACIP Expands Pfizer RSV Vaccine for At-Risk Adults 50-59
Public Records Staff Cuts Risk Government Accountability
Pfizer Updates on Oral GLP-1 Drug Danuglipron
New Immune Cell Discovery Sheds Light on Food Allergies
Pfizer Sets Virtual 2025 Shareholders Meeting for April 24
Innovating Health's Future Through Entrepreneurship
US Vaccine Investment Yields Strong Returns
EU Approves Pfizer's ABRYSVO RSV Vaccine for Adults 18-59
Dame June Raine: Innovations Boosting Healthcare Speed
Gut Sensor Discovery Boosts Intestinal Movement
Fatty Liver Tied to Higher Risk of Death from Diseases
Andri Papakonstantinou Awarded Swedish Oncology Scholarship
Australias PBS Cuts Costs for Pricey Meds: Heres How
WHO Approves First Maternal RSV Vaccine
Are We Ready For Next Pandemic?
Parkinson's, Restless Leg Drugs Tied to Risky Behavior
Early PSA Checks Post-Surgery Risk Overtreatment
Arvinas, Pfizer Report Positive Phase 3 VERITAC-2 Results
COVID-19 Shows Biomedical Advances Alone Can't End Disease
Kenvue Adds Three to Board of Directors
5 Years On, COVID Still New Zealand's Top Infectious Threat
New Tool Aids in Spotting Frail Seniors in Epic
Paxlovid Less Effective in Vaccinated Older Adults
Radiation, Immunotherapy May Preserve Bladder in Cancer
Rural Australia Sees Boost from Mobile GP Education Program
AI Boosts Heart Failure Trial Enrollment Speed
FDA OKs Pfizer's ADCETRIS Combo for Relapsed Lymphoma
Engineer Applies Covid Lessons To Cancer
Pfizer, Astellas' PADCEV Plus KEYTRUDA Shows Efficacy